Pharmaceutical technology, put to work.
Pete Pharmaceuticals was founded to bring pharmaceutical-grade technology, rigorous research and formulation expertise to the people who make medicine and the brands that make products. We are the U.S. partner for the FabRx M3DIMAKER, the developer of a growing library of validated 3D-printed formulas and the bases they print from, and the maker of NanoSil and TS-88.
A pharmacy-first approach to innovation
With over a decade of global research by FabRx behind the platform, Pete Pharma puts proven technology directly into the hands of compounders. Patients get medicine that is more effective, more tailored to their needs and easier to take; pharmacies get a workflow with less labor, less waste and more precision; prescribers get dosage forms that fit the patient instead of the other way round.
Evidence-based by default
Every formula in the Pete Pharma library carries USP dissolution and potency testing, a master formulation record and printing settings. We follow cGMP, USP and FDA regulations in how we develop and document, and we design experiments properly: controls, randomization and appropriate statistics, so that what we hand a pharmacy holds up.
Our commitment
Research and testing. Compliance. Validation and quality. Innovation is an ongoing journey in medicine and in consumer product manufacturing, and we intend to keep leading it.
Research & testing
Rigorous experimental design behind every formula and material.
Compliance
USP <795>/<797>, cGMP and FDA guidance built into how we work.
Validation & quality
Dissolution and potency on every formula; per-unit QC on every print.
Partnership
No software or maintenance fees. We earn only when our partners earn.
The M3DIMAKER platform was developed by FabRx, founded by world experts in pharmaceutical 3D printing from University College London, and refined over a decade with collaborators including Great Ormond Street Hospital, Vall d’Hebron University Hospital, Erasmus MC, the University of Cambridge, Monash University, Pfizer and AstraZeneca. Its first clinical studies of 3D-printed personalised medicines were published in 2019. Pete Pharma brings the platform, validated formulas and bases to U.S. compounding.
You produce. You profit. We earn only when you earn.
No software fees, no user fees, no maintenance fees. Pete Pharma’s incentives are aligned with the pharmacy’s from the first print.
- Dissolution and potency testing completed on every formula
- Onsite installation and workflow integration
- Unlimited software users on the printer
- Prescriber- and patient-facing marketing materials
- A partner portal with every formula, mold spec and support request in one place
The M3DIMAKER completely changed how we compound. What used to take hours now takes minutes. The quality is consistent, the workflow is simple, and the ROI was obvious after just one month.
Arizona, serving the U.S.
Pete Pharmaceuticals is based in Arizona and works with compounding pharmacies, 503B facilities, hospitals, research groups and product brands across the United States.
See any dosage form printed in minutes.
A 30-minute live demo with the Pete Pharma team, on your schedule. Or send us a question and we will reply the same business day.